XML 120 R104.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting - Segment Information about Reported Product Revenues, Depreciation and Amortization and Operating Income (Loss) (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Product Revenues      
Product revenues $ 1,456,124 $ 1,469,076 $ 1,204,656
Significant Segment Expenses and Operating Performance      
Cost of sales 1,089,693 1,117,452 931,006
Net research and development expenses 88,697 94,358 85,722
Selling, general and administrative expenses 155,108 155,579 132,693
Restructuring expenses, net 13,110 4,739 637
Impairment of intangible assets and property and equipment 2,501   6,291
Operating income (loss) 107,015 77,439 48,307
Other segment disclosures      
Depreciation and amortization 52,975 50,948 44,394
Operating Segments      
Product Revenues      
Product revenues 1,456,124 1,469,076 1,204,656
Corporate and Other Unallocated Expenses      
Significant Segment Expenses and Operating Performance      
Other operating expenses (92,966) (86,283) (66,097)
Corporate and other unallocated expenses (92,966) (86,283) (66,097)
Other segment disclosures      
Depreciation and amortization 1,681 1,449 1,235
Automotive Segments      
Product Revenues      
Product revenues 1,406,278 1,422,952 1,161,616
Automotive Segments | Operating Segments      
Product Revenues      
Product revenues 1,406,278 1,422,952 1,161,616
Significant Segment Expenses and Operating Performance      
Cost of sales 1,058,989 1,090,941 898,260
Net research and development expenses 68,787 70,778 75,137
Selling, general and administrative expenses 65,924 72,090 62,858
Restructuring expenses, net 12,238 3,187 637
Impairment of intangible assets and property and equipment     6,291
Operating income (loss) 200,340 185,956 118,433
Other segment disclosures      
Depreciation and amortization 47,752 45,845 39,815
Medical Segments | Operating Segments      
Product Revenues      
Product revenues 49,846 46,124 43,040
Significant Segment Expenses and Operating Performance      
Cost of sales 25,868 24,619 24,938
Restructuring expenses, net 20 363  
Other operating expenses 21,836 24,230 22,131
Impairment of intangible assets and property and equipment 2,501 19,509  
Operating income (loss) (359) (22,234) (4,029)
Corporate and other unallocated expenses 21,836 24,230 22,131
Other segment disclosures      
Depreciation and amortization $ 3,542 $ 3,654 $ 3,344